婴儿肺功能检查在婴儿神经内分泌细胞增生症诊断中的应用
本研究为观察性病例对照研究,评估2008至2018年登记患者的婴儿肺功能检查(iPFT)结果,比较NEHI婴儿与两个疾病对照组及一个肺量计正常对照组。NEHI婴儿表现为显著气体陷闭,功能残气量(FRCpleth)中位数199%预计值,FRCpleth≥150%预计值诊断NEHI的ROC为0.91,敏感性86.7%,特异性95.5%。
要点
- NEHI婴儿iPFT特征为显著气体陷闭,FRCpleth中位数199%预计值。
- FRCpleth≥150%预计值对NEHI诊断特异性高(95.5%)。
- 气流受限在NEHI与疾病对照组间相似,但气体陷闭突出。
核心结论
- iPFT显示气体陷闭程度与气流受限不成比例是NEHI婴儿的特征。
- FRCpleth≥150%预计值对NEHI高度特异,可能有助于早期诊断。
研究设计与样本
- 观察性病例对照研究,评估2008至2018年Hadassah希伯来大学医学中心登记患者的iPFT结果。
- 共纳入481名婴儿:15例NEHI、292例反复喘息、128例早产、46例肺量计正常对照组。
主要发现
- NEHI婴儿FRCpleth中位数199%预计值,残气量/肺总量比值中位数59%预计值,显著高于所有其他组(P < .001)。
- NEHI婴儿气流受限与两个疾病对照组相似,但显著高于肺量计正常对照组。
- FRCpleth对NEHI诊断的ROC为0.91(95% CI, 0.82-1.00)。
关键数值与推荐
- FRCpleth≥150%预计值诊断NEHI的敏感性86.7%(95% CI, 59.5%-98.3%),特异性95.5%(95% CI, 93.2%-97.3%)。
临床怎么用
- 对于怀疑NEHI的婴儿,iPFT显示FRCpleth≥150%预计值可支持早期诊断。
- 需注意NEHI气流受限程度与疾病对照组相似,诊断应结合气体陷闭指标。
局限性
- 需在前瞻性队列中进一步验证这些发现。
- 这些发现的病理生理学解释尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infant pulmonary function tests (iPFTs) in subjects with neuroendocrine cell hyperplasia of infancy (NEHI) have demonstrated substantial expiratory airflow obstruction and air trapping. RESEARCH QUESTION: Can indices from iPFTs be used in the diagnosis of NEHI? STUDY DESIGN AND METHODS: This is an observational case-control study evaluating iPFT results from a registry of patients assessed at the Hadassah Hebrew University Medical Center between 2008 and 2018. iPFTs results in infants with NEHI were compared to two disease control infant groups (infants evaluated for recurrent wheezing and infants evaluated due to prematurity) and a spirometry control group of infants with normal expiratory airflow, using the Kruskal-Wallis test. Receiver operating characteristic (ROC) curves were used to assess the diagnostic accuracy of iPFT indices. RESULTS: We evaluated iPFT data in 481 infants (15, NEHI; 292, wheezing; 128, premature; and 46, spirometry control group). Infants with NEHI had significantly increased trapped air volumes (median functional residual capacity measured with infant whole-body plethysmography [FRCpleth] was 199% predicted; median ratio of residual volume to total lung capacity was 59% predicted) when compared with results in all evaluated groups of infants (P < .001), including multiple pairwise comparisons. Airflow limitation was demonstrated in infants with NEHI when compared with the infants in the spirometry control group but was similar to the two disease control groups. FRCpleth had the best discriminatory ability for NEHI diagnosis, with an FRCpleth ≥ 150% predicted demonstrating a ROC of 0.91 (95% CI, 0.82-1.00), sensitivity of 86.7% (95% CI, 59.5%-98.3%), and specificity of 95.5% (95% CI, 93.2%-97.3%). INTERPRETATION: Findings on iPFTs of markedly increased air trapping, out of proportion to the degree of airflow limitation, are characteristic of infants with NEHI. iPFT results demonstrating an FRCpleth ≥ 150% predicted are highly specific for NEHI and may aid in early diagnosis. Further research is required to confirm these findings in a prospective cohort and to understand the pathophysiologic explanation for these findings.
引用
- Breuer O, Cohen-Cymberknoh M, Picard E, et al. The Use of Infant Pulmonary Function Tests in the Diagnosis of Neuroendocrine Cell Hyperplasia of Infancy. Chest. 2021. PMID: 34029568. doi:10.1016/j.chest.2021.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。